These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 7139969)
1. Proceedings of the symposium Mineralocorticoids in Essential and Secondary Hypertension. Newport Beach, California, February 28, 1982. Clin Exp Hypertens A; 1982; 4(9-10):1447-934. PubMed ID: 7139969 [No Abstract] [Full Text] [Related]
2. [Arterial hypertension (author's transl)]. Plaza de los reyes M Rev Med Chil; 1974 Nov; 102(11):861-8. PubMed ID: 4376609 [No Abstract] [Full Text] [Related]
3. The adrenal cortex and hypertension. Mulrow PJ Prim Care; 1983 Mar; 10(1):87-98. PubMed ID: 6553941 [No Abstract] [Full Text] [Related]
5. [Hypertension and mineralocorticoids. Usefulness of renin and aldosterone measurements]. Fardella CE; Montero J; Mosso L Rev Med Chil; 1999 May; 127(5):604-10. PubMed ID: 10451632 [TBL] [Abstract][Full Text] [Related]
6. The adrenal cortex and hypertension: some observations on a possible role for mineralocorticoids other than aldosterone. Fraser R; Brown JJ; Brown WC; Ferriss JB; Kennedy A; Lever AF; Mason PA; Morton JJ; Nicholls MG; Ramsay LE; Robertson JI; Schalekamp MA; Wilson A J Steroid Biochem; 1976; 7(11-12):963-70. PubMed ID: 192947 [No Abstract] [Full Text] [Related]
7. [Mineralocorticoids and hypertension]. Glorioso N; Soro A Cardiologia; 1998 Mar; 43(3):241-51. PubMed ID: 9611851 [No Abstract] [Full Text] [Related]
9. A symposium: International update--the important role of aldosterone and aldosterone antagonism in cardiovascular medicine. Based on symposia held in Brussels, Belgium and Newport Beach, California. Am J Cardiol; 1990 Jun; 65(23):1K-57K. PubMed ID: 2353664 [No Abstract] [Full Text] [Related]
10. Mineralocorticoid-stimulating activity of adipose tissue. Lamounier-Zepter V; Ehrhart-Bornstein M; Bornstein SR Best Pract Res Clin Endocrinol Metab; 2005 Dec; 19(4):567-75. PubMed ID: 16311217 [TBL] [Abstract][Full Text] [Related]
11. Mineralocorticoids and cardiovascular diseases. Status of knowledge from experimental and clinical studies. Pasquale PD; Stefano GD; Paterna S Ital Heart J; 2000 Sep; 1(9):595-604. PubMed ID: 11130838 [TBL] [Abstract][Full Text] [Related]
13. [Effects of mineralocorticoids on RNA content of cells of kidney tubules and salivary gland ducts in rats]. Krestinskaia TV; Ovchinnikova LP Tsitologiia; 1967 Feb; 9(2):231-3. PubMed ID: 6077287 [No Abstract] [Full Text] [Related]
14. [Mineralocorticoid hypertension. A new form of secondary hypertension?]. Román O Rev Med Chil; 1999 May; 127(5):511-3. PubMed ID: 10451619 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms of action of mineralocorticoid hormones. Rossier BC Endocr Res; 1989; 15(1-2):203-26. PubMed ID: 2667967 [No Abstract] [Full Text] [Related]
16. How can aldosterone act as a mineralocorticoid? Funder JW Endocr Res; 1989; 15(1-2):227-38. PubMed ID: 2759049 [No Abstract] [Full Text] [Related]
17. Aldosterone and Hypertension. Proceedings of a satellite symposium to the 15th International Society of Hypertension Congress. Lorne, Victoria, Australia, March 17-19, 1994. Steroids; 1995 Jan; 60(1):1-186. PubMed ID: 7792791 [No Abstract] [Full Text] [Related]
18. Symposium on the adrenal cortex. Proceedings of a conference. Newport Beach, California, June 22-23, 1986. Endocr Res; 1986; 12(4):315-524. PubMed ID: 3830095 [No Abstract] [Full Text] [Related]
20. Liquorice: new insights into mineralocorticoid and glucocorticoid hypertension. Morris DJ R I Med; 1993 May; 76(5):251-4. PubMed ID: 8518501 [No Abstract] [Full Text] [Related] [Next] [New Search]